Blog
Bagaimana Pemerintah Bisa Mengubah Penelitian Universitas Menjadi Inovasi Komersial untuk UKM
Bagaimana Pemerintah Bisa Mengubah Penelitian Universitas Menjadi Inovasi Komersial untuk UKM
Isi kandungan
Isi kandungan
Universities produce research, and SMEs need practical innovation, but a working research commercialization ecosystem is usually what’s missing to connect with the two.
Universities produce research that could help businesses innovate, but SMEs often lack a practical route to access, test and apply it. A functioning research commercialization ecosystem connects these groups, helping promising research become usable technologies, digital solutions and business improvements.
The sections below cover why research rarely reaches SMEs, what the ecosystem contains, where government has leverage, how SMEs absorb research, and how to measure success.
Why Does Research Rarely Reach SMEs on Its Own?
Universities and SMEs operate on different incentives. A researcher is usually rewarded for publishing and securing grants, not for commercializing a result, so the step from discovery to product is often nobody’s job. SMEs face narrow margins and short planning horizons, which makes an unproven technology a hard sell next to a safer, incremental improvement.
The two sides also speak different languages. Academic papers describe mechanisms and statistical significance; SME owners want to know what a technology does, what it costs to adopt, and how soon it pays back. Without translation, a genuinely useful finding can sit unread by the people who could use it.
Risk tolerance compounds the gap. A university lab can absorb years of experimentation because its funding model expects some projects to fail; a small business usually cannot, so research has to be substantially de-risked before an SME will touch it.
Finally, many SMEs lack the absorptive capacity to use new research even when it’s offered to them. Adopting a new process takes technical know-how, spare management time, and tolerance for disruption, all in short supply at smaller firms. An ecosystem has to account for this rather than treat it as the SME’s problem alone.
What Does a Research Commercialization Ecosystem Contain?
A functioning ecosystem is less a single program than a set of connected components, each addressing a different friction point between a lab result and a market-ready offering.| Component | What it does | Who typically funds it |
|---|---|---|
| Technology transfer office | Identifies commercially promising research inside a university, files and manages IP, negotiates licenses | University, sometimes co-funded by government |
| Proof-of-concept funding | Bridges the gap between a lab finding and a product a business could evaluate | Government grants, university seed funds |
| IP and licensing rules | Set out who owns research IP and on what terms it can be licensed to industry | National or institutional policy |
| Incubators and spin-outs | House and support new companies formed around university research | University, government, private investors |
| Industry liaison functions | Connect researchers with businesses that have a real operational problem to solve | University, industry associations, government |
A dedicated university technology transfer function helps identify commercially promising research, manage IP and connect potential users with researchers. Depending on the region, this work may sit within a university office or be supported by a shared intermediary.
Proof-of-concept funding covers the stage where a result is too early for private investment but too advanced to stay purely academic. IP and licensing rules determine whether a business can use a technology without protracted negotiation, and incubators give promising university spin-outs somewhere to mature into a company. Industry liaison roles introduce the two sides to each other.
What Can Government Do That Others Cannot?
Universities and private investors can build pieces of this ecosystem alone, but government has several distinctive levers — funding design, public IP policy, and procurement power chief among them — and research commercialization policy is largely about using them well.
Funding design is the most direct lever: government can fund proof-of-concept and early-stage translation work that falls between academic grants and venture capital, where private investment may be difficult to secure. IP policy is another — setting default rules on who owns publicly funded research, and on what terms it can be licensed, shapes incentives for every university and company in the system.
Government is also a buyer. Procurement can act as a demand pull, giving a research-based product its first real customer when private buyers are still cautious. Innovation vouchers for SMEs — small grants a firm uses to buy research services from a university — are a cost-effective way to subsidize that first contact without running a large program.
Finally, government can convene — bringing together technology transfer offices, SME associations, and investors who wouldn’t otherwise coordinate, a practical way to reduce coordination barriers within a government innovation ecosystem.
How Do SMEs Actually Absorb Research?
SMEs rarely adopt research directly from a journal, absorbing it instead through intermediate steps that lower the cost and risk of engagement. Innovation vouchers let a small firm commission a bounded piece of work from a university rather than committing to an open-ended R&D relationship. Shared labs and testbeds give SMEs access to equipment and expertise they could never justify buying themselves.
Talent placements — a researcher or graduate working inside an SME for a fixed period — can be more effective than formal technology transfer at moving tacit, hands-on knowledge, because they put expertise directly inside the business rather than handing over a report. Simple, standardized licensing terms matter too: a small business without a legal department will often walk away from a technology rather than negotiate a complex license.
Underneath all of this sits a skills gap. Many SMEs lack staff who can evaluate research or integrate a new technology into existing operations, which is why absorption support — not just access to research — has to be part of the ecosystem design.
How Should a Region Measure Success?
Counting published papers or research spending tells a government almost nothing about whether an ecosystem is working. More useful measures include licenses signed with SMEs specifically, rather than large corporates; spin-out companies formed and still operating after a few years; and direct SME adoption rates for university-originated technology.
Downstream indicators matter too: jobs created in firms that adopted research-based innovation, and follow-on private investment attracted by spin-outs or licensed technology, can help assess the ecosystem’s contribution beyond the original grant, though neither can be attributed to the program alone. Regions should avoid vanity counts — total patents or papers published say little about commercial impact — and instead track what actually reaches and changes an SME’s operations.
Whichever measures a region chooses, it should define them consistently — a fixed time window, a clear baseline, and an explicit SME-size threshold — track outcomes over several years rather than one, and distinguish outputs such as licenses signed from outcomes such as jobs created or revenue generated.
Research commercialization is one part of a broader digital economy transformation strategy. Governments need an integrated ecosystem that connects talent development, industry-relevant innovation and enterprise adoption to translate institutional capabilities into economic outcomes.
Melalui Digital Economy Transformation approach, CLaaS2SaaS supports this broader vision through Learn2Work Convergence, AI-Innovation Hubs and the Pan-ASEAN AI Marketplace — connecting government, academia, industry and businesses to accelerate AI talent development, innovation and adoption across ASEAN.
Pertanyaan umum
Can AI agents approve purchases on their own?
They should not make final approvals on regulated or high-value spend. Agents are better used to triage requests, check them against policy and grant rules and prepare vendor information, while people with delegated authority approve exceptions and high-value purchases.
How does this help grant-funded purchasing?
It pre-checks funds and allowability against the grant’s stated conditions before approval, so problems surface early. The funder’s terms and research administration still decide what is allowable.
Does this replace procurement staff?
No. It shifts time from routine checking toward exceptions, vendor strategy and working with departments and researchers.
What data is needed first?
A clean vendor master and consistent category data, plus current policy and grant conditions in a usable form. Duplicate or incomplete vendor records are worth fixing first.
Which spend category should be piloted?
A high-volume, low-risk category, such as lab consumables, where outcomes are easy to measure and errors are easy to correct.































